Septerna (SEPN) Total Current Liabilities (2023 - 2026)
Septerna's (SEPN) quarterly Total Current Liabilities came in at $78.2 million in Q1 2026, up 634.77% year-on-year from $10.6 million in Q1 2025, and down 10.08% quarter-over-quarter from $86.9 million in Q4 2025.
Septerna (SEPN) Total Current Liabilities (2023 - 2026) Analysis & Trends
Septerna's Total Current Liabilities history runs 4 years deep, the most recent figure standing at $78.2 million for Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 634.77% year-over-year to $78.2 million in Q1 2026; TTM through Mar 2026 was $78.2 million, a 634.77% increase from a year earlier, with the FY2025 full-year figure at $86.9 million, up 576.56% from the prior year.
- Total Current Liabilities slipped to $78.2 million in Q1 2026 per SEPN's latest filing, from $86.9 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $86.9 million in Q4 2025 and bottomed at $6.9 million in Q4 2023.
- The 4-year median for Total Current Liabilities is $14.2 million (2024), against an average of $37.4 million.
- Across the five-year window, Total Current Liabilities surged 85.84% in 2024 and soared 634.77% in 2026, its largest moves.
- Year by year, Total Current Liabilities stood at $6.9 million in 2023, then jumped by 85.84% to $12.8 million in 2024, then soared by 576.56% to $86.9 million in 2025, then fell by 10.08% to $78.2 million in 2026.
- Per Business Quant, the three latest SEPN Total Current Liabilities figures stand at $78.2 million (Q1 2026), $86.9 million (Q4 2025), and $75.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Septerna | 1.50 Bn | 1.50 Bn | - | 78.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78.17 Mn |
| Dec 31, 2025 | 86.93 Mn |
| Sep 30, 2025 | 75.28 Mn |
| Jun 30, 2025 | 15.13 Mn |
| Mar 31, 2025 | 10.64 Mn |
| Dec 31, 2024 | 12.85 Mn |
| Sep 30, 2024 | 13.23 Mn |
| Dec 31, 2023 | 6.91 Mn |